Jim Miller

How have procurement and supply-chain executives from bio/pharma companies and their suppliers responded to recent unprecedented sourcing challenges and the resulting need to re-evaluate sourcing and supply-chain management functions? The latest study from DCAT Research & Benchmarking highlights the changes in sourcing and supply-chain strategies and organizations.

After a robust 2021, the CDMO industry entered 2022 with a lot of momentum, but at the close of 1Q 2022, market conditions are more uncertain. Highlights from a DCAT Week 2022 presentation.

A newly released DCAT benchmarking study examines the targets and progress made by bio/pharma companies and suppliers in reaching their sustainability goals.